RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity
Dermatology Times Mar 19, 2023 Kaitlyn Bader Read the Full Article >> A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA. There is a lack of evidence investigating the impact of patient-reported outcomes (PROs) monitoring in routine clinical practice, according to a[…]